Veyong Pharma yitabiriye kuri 22 ya cphi China 2024

Kuva ku ya 19 kugeza ku ya 21 kugeza ku ya 21, CPHI 4Ni Ubushinwa na 17 w'Ubushinwa byakorewe mu kigo gishya cya Expoin Shanghai. Li Jiajie, Umuyobozi mukuru waVeyongDharma, ishami rya farumasili ya liman, Dr. SI Zhenika, Umuyobozi wa ROBONUN, Umuyobozi wa LaBeratory R & DIEPQuu, Nie Fenthiuu, Umuyobozi wa Laboratoire R & D, Li JIEQING, Umuyobozi mukuru w'ikigo mpuzamahanga cyo kwamamaza kwamamazaVeyongPharma, na Chen Lusheng, Umuyobozi w'ishami rishinzwe imiyoborere mu micungire, yitabiriye imurikagurisha n'itsinda ryabo mpuzamahanga ryo kwamamaza.

Kuri Booth E2A20,VeyongPharma yerekanweivermectin, abamectin, tIamulin Fumarate, epininictinn'ibindi bicuruzwa kuriabakiriyaku isi yose. Ibicuruzwa biyobora isosiyete byanyuze kuri FDA na EPE CDA na EU CEP byinjiraga imbere ku isoko mpuzamahanga ryinyuma. Imiterere yacyo itunganijwe, ibicuruzwa byizewe byimikorere nibicuruzwa bikungahaye ku bicuruzwa byatoneshwaga namurikabikorwa benshi.

Imurikagurisha ryaranshingewe n'abantu. Ikipe mpuzamahanga yo kwamamaza yari yuzuyeho yuzuye, yari ifite imyumuza mu buryo bwimbitse abashyitsi babaye, bateze amatwi bitonze ibikenewe by'abakiriya, kandi batanga ibisubizo by'umwuga, bagaragaza imbaraga zumwuga nubufatanye agaciro kaVeyongku isoko ryisi yose, kandi yashyizeho isano nini nabashobora kubabara kurubuga.

Iri murika ryaramutseVeyongImiyoboro yo kugurisha ya Pharma ku isoko mpuzamahanga kandi yahujije kandi izina ry'ikigo n'ingaruka ku isoko mpuzamahanga rya API. Mu bihe biri imbere, isosiyete izakomeza kwihutisha umuvuduko w'iterambere ryisoko mpuzamahanga kandi ryongerera imbereVeyongIkirangantego cya Pharma hamwe no guhatanira isoko mukibuga cya APISno kwitegura.